To understand the mechanism of VSIG4 in tumor development, the potential functional target cells of VSIG4, including CD4+, CD8+, and NK cells, were depleted with specific monoclonal antibodies after tumor harboring (Fig. 3A). This evidence concerns the gene VSIG4 and neoplasm.